Publisher
Springer International Publishing
Reference69 articles.
1. Kanayama G, Pope HG Jr. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4–13.
2. Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2013;35(3):341–75.
3. Monitoring the Future. National survey results of drug use. [Internet]. 2018 [cited 2019 May 2]. Available from:
http://www.monitoringthefuture.org/data/18data/18drtbl5.pdf
.
4. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007;88(2–3):156–62.
5. Cafri G, Olivardia R, Thompson JK. Symptom characteristics and psychiatric comorbidity among males with muscle dysmorphia. Compr Psychiatry. 2008;49(4):374–9.